Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Observation of Treatment Patterns With Lucentis® (Ranibizumab) in Real-life Conditions in All Approved Indications
Authors not listed
Novartis Pharmaceuticals · 2015
Abstract
This study is designed as an observational, non-interventional, multicenter, open label, single arm study in patients being treated with Lucentis® for any approved indication included in the local product posology.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-10-26 MST
Cite this
APA
Anonymous. (2015). Observation of Treatment Patterns With Lucentis® (Ranibizumab) in Real-life Conditions in All Approved Indications. <em>Novartis Pharmaceuticals</em>. https://clinicaltrials.gov/study/NCT04847895
Vancouver
Anonymous. Observation of Treatment Patterns With Lucentis® (Ranibizumab) in Real-life Conditions in All Approved Indications. Novartis Pharmaceuticals. 2015.
BibTeX
@misc{anon2015Observ,
title = {Observation of Treatment Patterns With Lucentis® (Ranibizumab) in Real-life Conditions in All Approved Indications},
author = {Anonymous},
journal = {Novartis Pharmaceuticals},
year = {2015},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Insel Gruppe AG, University Hospital Bern 2006
Open access · US-GOV
Open-label, Phase II Study Assessing Immediate Effects of Lucentis®(Ranibizumab) Administered in Conjunction With Photodynamic Therapy With Visudyne® in Patients With Choroidal Neovascularization Secondary to AMD
Imperial College London 2021
Open access · US-GOV
Vascular Frailty - An Observational Cohort Study
Hospital Universitario de Gran Canaria Doctor Negrín 2024
Open access · US-GOV
Perioperative Frailty and Postoperative Complications: a Prospective Study
University Hospital, Basel, Switzerland 2006
Open access · US-GOV
Randomized, Phase IIIb Study Comparing Safety, Tolerability and Efficacy Between Lucentis® Administered in Conjunction With PDT With Visudyne® and Lucentis® in Patients With Subfoveal CNV Secondary to Age-Related Macular Degeneration
Istituto Nazionale di Ricovero e Cura per Anziani 2025
Open access · US-GOV
Blood Biomarkers for Alzheimer Disease and Neuro-injury to Estimate the Association With Cognitive/Functional Decline and Mortality in a Real-world Population of GERiatric Hospitalized Patients (BAD-GER): a Multicenter, Observational, 3-arms, Prospective Study
Neurological Associates of West Los Angeles 2021
Open access · US-GOV